Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic

Objectives To carry out a further survey of archived appendix samples to understand better the differences between existing estimates of the prevalence of subclinical infection with prions after the bovine spongiform encephalopathy epizootic and to see whether a broader birth cohort was affected, and to understand better the implications for the management of blood and blood products and for the handling of surgical instruments. Design Irreversibly unlinked and anonymised large scale survey of archived appendix samples. Setting Archived appendix samples from the pathology departments of 41 UK hospitals participating in the earlier survey, and additional hospitals in regions with lower levels of participation in that survey. Sample 32 441 archived appendix samples fixed in formalin and embedded in paraffin and tested for the presence of abnormal prion protein (PrP). Results Of the 32 441 appendix samples 16 were positive for abnormal PrP, indicating an overall prevalence of 493 per million population (95% confidence interval 282 to 801 per million). The prevalence in those born in 1941-60 (733 per million, 269 to 1596 per million) did not differ significantly from those born between 1961 and 1985 (412 per million, 198 to 758 per million) and was similar in both sexes and across the three broad geographical areas sampled. Genetic testing of the positive specimens for the genotype at PRNP codon 129 revealed a high proportion that were valine homozygous compared with the frequency in the normal population, and in stark contrast with confirmed clinical cases of vCJD, all of which were methionine homozygous at PRNP codon 129. Conclusions This study corroborates previous studies and suggests a high prevalence of infection with abnormal PrP, indicating vCJD carrier status in the population compared with the 177 vCJD cases to date. These findings have important implications for the management of blood and blood products and for the handling of surgical instruments.

[1]  D. Balding,et al.  Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP. , 2012, Human molecular genetics.

[2]  H. Laude,et al.  Facilitated Cross-Species Transmission of Prions in Extraneural Tissue , 2012, Science.

[3]  J. Collinge,et al.  Effect of fixation on brain and lymphoreticular vCJD prions and bioassay of key positive specimens from a retrospective vCJD prevalence study , 2011, The Journal of pathology.

[4]  Azra C. Ghani,et al.  Uncertainty in the Tail of the Variant Creutzfeldt-Jakob Disease Epidemic in the UK , 2010, PloS one.

[5]  J. Linehan,et al.  Large‐scale immunohistochemical examination for lymphoreticular prion protein in tonsil specimens collected in Britain , 2010, The Journal of pathology.

[6]  N. Greenspan,et al.  PrP Conformational Transitions Alter Species Preference of a PrP-specific Antibody* , 2010, The Journal of Biological Chemistry.

[7]  J. Ironside,et al.  Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey , 2009, BMJ : British Medical Journal.

[8]  S. J. Moore,et al.  Accumulation and dissemination of prion protein in experimental sheep scrapie in the natural host , 2009, BMC veterinary research.

[9]  N. Hunter,et al.  Prion diseases are efficiently transmitted by blood transfusion in sheep. , 2008, Blood.

[10]  G. Georgsson,et al.  High incidence of subclinical infection of lymphoid tissues in scrapie-affected sheep flocks , 2008, Archives of Virology.

[11]  James W Ironside,et al.  Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study , 2006, BMJ : British Medical Journal.

[12]  J. Collinge,et al.  High levels of disease related prion protein in the ileum in variant Creutzfeldt-Jakob disease , 2005, Gut.

[13]  J Collinge,et al.  Molecular neurology of prion disease , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[14]  J. Collinge,et al.  Human Prion Protein with Valine 129 Prevents Expression of Variant CJD Phenotype , 2004, Science.

[15]  Lorraine C. Smith,et al.  Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein , 2004, The Lancet.

[16]  M. Head,et al.  Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient , 2004, The Lancet.

[17]  Mark Penney,et al.  Prevalence of lymphoreticular prion protein accumulation in UK tissue samples , 2004, The Journal of pathology.

[18]  C. Wiley,et al.  Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt–Jakob disease , 2004, Journal of Clinical Pathology.

[19]  J. Collinge,et al.  BSE prions propagate as either variant CJD‐like or sporadic CJD‐like prion strains in transgenic mice expressing human prion protein , 2002, The EMBO journal.

[20]  J. Collinge,et al.  Cytokine profiles in HIV seropositive patients with tuberculous meningitis , 2002, Journal of neurology, neurosurgery, and psychiatry.

[21]  A. Ghani,et al.  Accumulation of prion protein in tonsil and appendix: review of tissue samples , 2002, BMJ : British Medical Journal.

[22]  A. Aguzzi,et al.  Chronic Subclinical Prion Disease Induced by Low-Dose Inoculum , 2002, Journal of Virology.

[23]  P. Lantos,et al.  Species-barrier-independent prion replication in apparently resistant species. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Ghani,et al.  Retrospective study of prion-protein accumulation in tonsil and appendix tissues , 2000, The Lancet.

[25]  J Collinge,et al.  Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples , 1999, The Lancet.

[26]  J. Zajicek,et al.  Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease , 1998, The Lancet.

[27]  Andrew F. Hill,et al.  The same prion strain causes vCJD and BSE , 1997, Nature.

[28]  M. Zeidler,et al.  Codon 129 genotype and new variant CJD , 1997, The Lancet.

[29]  DavidJ. Evans,et al.  Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy , 1997, The Lancet.

[30]  R. B. Petersen,et al.  Typing prion isoforms , 1997, Nature.

[31]  C. Donnelly,et al.  Transmission dynamics and epidemiology of BSE in British cattle , 1997, Nature.

[32]  P. Lantos,et al.  Prion protein immunocytochemistry – UK five centre consensus report , 1997, Neuropathology and applied neurobiology.

[33]  Andrew F. Hill,et al.  Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD , 1996, Nature.

[34]  C. Windle,et al.  Failure to transmit bovine spongiform encephalopathy to marmosets with ruminant-derived meal , 1996, The Lancet.

[35]  J. Collinge,et al.  Prion protein gene analysis in new variant cases of Creutzfeldt-Jakob disease , 1996, The Lancet.

[36]  K. Onozaki,et al.  Isolation and long-term cultivation of human tonsil follicular dendritic cells , 1990, Virchows Archiv. B, Cell pathology including molecular pathology.

[37]  H. Wiśniewski,et al.  Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins , 1987, Journal of virology.